Page last updated: 2024-11-04

vorinostat and Acute Post-Traumatic Stress Disorder

vorinostat has been researched along with Acute Post-Traumatic Stress Disorder in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
"Vorinostat was intraperitoneally injected immediately after second extinction training session."1.39Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder. ( Fujita, Y; Matsumoto, T; Matsumoto, Y; Morinobu, S; Takei, S; Yamamoto, S; Yamawaki, S, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, Y1
Morinobu, S2
Yamamoto, S2
Matsumoto, T1
Takei, S1
Fujita, Y2
Yamawaki, S1

Reviews

1 review available for vorinostat and Acute Post-Traumatic Stress Disorder

ArticleYear
[Novel therapeutic approach for the treatment of post-traumatic stress disorder (PTSD): facilitating fear extinction].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2012, Volume: 32, Issue:4

    Topics: Acetyltransferases; Animals; Extinction, Psychological; Fear; Hydroxamic Acids; Male; Rats; Receptor

2012

Other Studies

1 other study available for vorinostat and Acute Post-Traumatic Stress Disorder

ArticleYear
Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder.
    Psychopharmacology, 2013, Volume: 229, Issue:1

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Extinction, Psy

2013